Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 22.86% is 122% above its 3-year average of -102.29%, near the high end of its 3-year range (-184.68%–22.86%).
As of the fiscal period ended Sunday, June 30, 2024. 188.50% above its 12-month average of -25.83%.
Annual fiscal-year EBITDA margin; no daily interpolation. Historical series through 2024-06-30.
EBITDA MARGIN
22.86%
EBITDA MARGIN AVG TTM
-25.83%
EBITDA MARGIN AVG 3Y
-102.29%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+188.50%
CURRENT VS 3Y AVG
+122.35%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Lite Strategy, Inc.
Market Cap
$47.94M
EBITDA Margin
22.86%
TTM Avg
-25.83%
3Y Avg
-102.29%
5Y Avg
N/A
Market Cap
$48.05M
EBITDA Margin
-11.13%
TTM Avg
-19.55%
3Y Avg
-13.57%
5Y Avg
-11.41%
Market Cap
$46.73M
EBITDA Margin
-24194.20%
TTM Avg
-24194.20%
3Y Avg
-24194.20%
5Y Avg
-24194.20%
Market Cap
$49.21M
EBITDA Margin
-40.79%
TTM Avg
-44.28%
3Y Avg
-63.47%
5Y Avg
-81.32%
Market Cap
$49.44M
EBITDA Margin
-30422.22%
TTM Avg
-16673.71%
3Y Avg
-8702.25%
5Y Avg
-6477.94%
Market Cap
$49.45M
EBITDA Margin
-61570.00%
TTM Avg
-181077.86%
3Y Avg
-90538.93%
5Y Avg
-60359.29%
Market Cap
$49.55M
EBITDA Margin
-36.10%
TTM Avg
-7.86%
3Y Avg
4.76%
5Y Avg
-6.98%
Market Cap
$49.24M
EBITDA Margin
-108.45%
TTM Avg
-10676.44%
3Y Avg
-10454.97%
5Y Avg
-429870.64%
Market Cap
$49.79M
EBITDA Margin
-203.44%
TTM Avg
-129.78%
3Y Avg
-288.25%
5Y Avg
-438.27%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $47.94M | 22.86% | -25.83% | -102.29% | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.05M | -11.13% | -19.55% | -13.57% | -11.41% |
| Instil Bio, Inc. (TIL)vs › | $46.73M | -24194.20% | -24194.20% | -24194.20% | -24194.20% |
| TELA Bio, Inc. (TELA)vs › | $49.21M | -40.79% | -44.28% | -63.47% | -81.32% |
| Microbot Medical Inc. (MBOT)vs › | $49.44M | -30422.22% | -16673.71% | -8702.25% | -6477.94% |
| INmune Bio, Inc. (INMB)vs › | $49.45M | -61570.00% | -181077.86% | -90538.93% | -60359.29% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | -36.10% | -7.86% | 4.76% | -6.98% |
| Apollomics, Inc. (APLM)vs › | $49.24M | -108.45% | -10676.44% | -10454.97% | -429870.64% |
| Celularity Inc. (CELU)vs › | $49.79M | -203.44% | -129.78% | -288.25% | -438.27% |
| DarioHealth Corp. (DRIO)vs › | $44.75M | -148.02% | -167.05% | -193.51% | -252.90% |
Gross Margin
0.0%
EBITDA Margin
22.9%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2024-06-30 | 22.86% |
| 2023-06-30 | -74.52% |
| 2022-06-30 | -184.68% |
| 2021-06-30 | -172.83% |
